Featured Peptides
Peptide
GLP-3 (10mg)
Synthetic GLP-3 receptor agonist for laboratory research
Peptide
BPC-157 / TB-500 Research Blend (20mg)
BPC-157 + TB-500 combination research blend
Peptide
KLOW Blend (80mg)
4-compound research blend (GHK-Cu, BPC-157, TB-500, KPV)
Peptide
BPC-157 (10mg)
15-amino acid synthetic peptide for tissue mechanism research
Peptide
TB-500 (10mg)
Synthetic 43-amino acid peptide for cell migration research
Peptide Catalog
Peptides
5-Amino-1MQ (10mg)
Small-molecule NNMT inhibitor for metabolic research
Peptides
BPC-157 (10mg)
15-amino acid synthetic peptide for tissue mechanism research
Peptides
GLP-3 (10mg)
Synthetic GLP-3 receptor agonist for laboratory research
Peptides
GLP-3 (30mg)
Synthetic GLP-3 receptor agonist for laboratory research
Peptides
IGF-1 LR3 (1mg)
Long-acting IGF-1 analog for cell-signaling research
Peptides
Kisspeptin (10mg)
10-amino acid neuropeptide for endocrine research
Peptides
Melanotan 2 (10mg)
Synthetic melanocortin receptor agonist for research
Peptides
MOTS-c (40mg)
Mitochondrial-derived peptide for cellular research
Peptides
PT-141 (10mg)
Synthetic melanocortin receptor agonist for research
Peptides
Semax (10mg)
Synthetic ACTH(4-10) analog for neurological research
Peptides
SS-31 (50mg)
Mitochondrial-targeted tetrapeptide for cellular research
Peptides
TB-500 (10mg)
Synthetic 43-amino acid peptide for cell migration research
Blends
BPC-157 / TB-500 Research Blend (20mg)
BPC-157 + TB-500 combination research blend
Blends
CJC no DAC 5mg / Ipamorelin 5mg
Research blend combining CJC-1295 No DAC (5mg) and Ipamorelin (5mg) for growth hormone secretagogue research.
Blends
KLOW Blend (80mg)
4-compound research blend (GHK-Cu, BPC-157, TB-500, KPV)
Third-Party Lab Tested
| Product | Batch | Purity | Date |
|---|---|---|---|
| NAD+ | CPND07-1 | 99.93% | 6/29/2026 |
| GLP-3 | CPRT07-2 | 99.78% | 6/29/2026 |
| SS-31 | CPSS07-1 | 99.90% | 6/29/2026 |
| MOTS-c | CPMC07-1 | 99.46% | 6/29/2026 |
| CJC no DAC 5mg / Ipamorelin 5mg | CPCP07-1 | 99.89% | 6/29/2026 |
| KLOW Blend | CPKL07-1 | 99.64% | 6/29/2026 |
| GHK-Cu (50mg) | CPGC07-1 | 99.77% | 6/29/2026 |
| GLP-3 | CPRT07-1 | 99.49% | 6/29/2026 |
| BPC-157 / TB-500 Research Blend | CPWV07-1 | 99.46% | 6/29/2026 |
| GLP-2 | CPTZ07-1 | 99.65% | 6/29/2026 |
| GLP-3 | CP-RT10-0605-1 | 99.81% | 6/9/2026 |
| BPC-157 / TB-500 Research Blend | CP-WV20-0531-1 | 99.72% | 6/4/2026 |
| Tesamorelin | CP-TSM10-0531-1 | 99.88% | 6/4/2026 |
| TB-500 | CP-TB5-0531-1 | 99.55% | 6/4/2026 |
| IGF-1 LR3 | CP-IGI-0531-1 | 99.82% | 6/4/2026 |
| GHK-Cu (50mg) | CP-GHK100-0531-1 | 99.87% | 6/4/2026 |
Showing all 16 tested batches — scroll the table to view more.
Stay Informed
Get notified about new product availability and lab test results.